How many institutional investors hold CLYM?

3 tracked institutional investors disclosed a position in CLYM (CLIMB BIO INC) in their most recent 13F filing.

Who is the largest institutional holder of CLYM?

Izzy Englander, Millennium Management, holds the largest disclosed position in CLYM, valued at $9M.

Where does this CLYM ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CLYM — CLIMB BIO INC

Name: CLIMB BIO INC (CLYM) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CLIMB BIO INC (CLYM)

CLIMB BIO INC (CLYM) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $9M. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CLYM

100

/100

Strong Institutional Accumulation

Added / Increased3

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track CLYM

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

CLYM Ownership Composition

How CLIMB BIO INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

96% of tracked value

Institutions

tracked investors

Total Reported

$11.5M

combined 13F value

Other96.5%
Hedge Funds3.5%

Other(2)

96.5%

Hedge Funds(1)

3.5%

Tracked investors reporting CLYM

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	1.3M	$8.7M	0.00%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	59.1K	$404.8K	0.00%	Mar 31, 2026
Ken Griffin	Citadel Advisors	345.7K	$2.4M	0.00%	Mar 31, 2026

Izzy EnglanderMar 31, 2026
Millennium Management
Shares
1.3M
Value
$8.7M
% Portfolio
0.00%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
59.1K
Value
$404.8K
% Portfolio
0.00%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
345.7K
Value
$2.4M
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$1.2M	Feb 17, 2026
Steve Cohen	New	—	$2.9M	Feb 17, 2026
Steve Cohen	New	—	$404.8K	May 15, 2026

Izzy Englander
New
$1.2MFeb 17, 2026
Steve Cohen
New
$2.9MFeb 17, 2026
Steve Cohen
New
$404.8KMay 15, 2026

Frequently asked questions

How many institutional investors hold CLYM?: 3 tracked institutional investors disclosed a position in CLYM (CLIMB BIO INC) in their most recent 13F filing.
Who is the largest institutional holder of CLYM?: Izzy Englander, Millennium Management, holds the largest disclosed position in CLYM, valued at $9M.
Did institutional ownership of CLYM increase or decrease?: Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 fully exited CLYM.
Where does this CLYM ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.